Automated Cell Counting Market Size To Reach $11.92 Billion By 2033

Automated Cell Counting Market Growth & Trends

The global automated cell counting market size is expected to reach USD 11.92 billion by 2033, registering a CAGR of 15.4% from 2026 to 2033, according to a new report by Grand View Research, Inc. Growing need for biologics in the prevention and treatment of chronic and infectious diseases, increased investment in the biotechnology & biopharmaceutical industries, and the development of advanced cell-based research are some of the factors driving market expansion. Biologics development necessitates the use of various cell counting equipment, including image-based counters and flow cytometers, to manage cell concentration in biologics, hence boosting the market's growth prospects.

The COVID-19 pandemic had an enormous impact on the utilization of cell-counting equipment and consumables. The pandemic saw an increase in the use of cell counting instruments, as osteopenia & lymphopenia were possible COVID-19 indicators. For instance, in June 2021, a study published in the journal BMC Infectious Diseases discovered that a high number of white blood cells upon admission was substantially associated with death in COVID-19 individuals. As a result, a greater number of white blood cells were taken into account when treating COVID-19. Due to such developments, the COVID-19 outbreak had a significant impact on the market growth.

The increased incidence of target diseases such as HIV, measles, diphtheria, & chronic diseases such as cancer and other blood disorders, as well as the increasing utilization of high-throughput flow cytometry & automated hematology analyzers, are the primary factors driving market expansion. According to UNAIDS data, an estimated 38.4 million individuals worldwide were living with HIV in 2022, while an estimated 1.5 million were newly infected with HIV in 2021. As a result, growing infectious illness cases are likely to drive up demand for cell counting instruments and consumables.

Increasing initiatives by leading market players to create improved cell counter devices have resulted in increased popularity of these products due to their numerous applications and ease of use. for example, Mindray introduced the new BC-700 Series in March 2022, an innovative hematology analyzer series that includes complete blood count (CBC) along with erythrocyte sedimentation rate (ESR) assays. Thus, boosting the market growth.

The market is benefiting from increased government & private investment for stem cell, cancer, & immunology research. Automated counting technologies are used in grant programs to advance cell biology and genomics research for applications such as phenotypic identification, cell sorting, as well as single cell analysis. For example, the National Institutes of Health (NIH) granted over $41 billion in healthcare research funding to universities and labs across the US in 2021, a substantial percentage of which was allocated to cell-based research programs. Thus, the availability of such funds and funding enables labs to obtain high-end automated cell analysis tools and further boost market growth.

 Request a free sample copy or view report summary: Automated Cell Counting Market Report

Automated Cell Counting Market Report Highlights

• The consumables & accessories segment is expected to witness the largest share in 2025 and the fastest CAGR during the forecast period. The segment is largely driven by its inherently recurring nature and essential role in operational workflows.

• The cell line development application segment held 31.59% of the global market share in 2025, accounting for the largest proportion of the market. Cell line development is an essential component of research and biological medicine production.

• The pharmaceutical & biotechnology companies segment dominated the global market share of 39.65% in 2025, The biopharma industry's rising emphasis on cell-based research & drug discovery is driving up the popularity of automated cell counters.

• North America automated cell counting market accounted for the largest share of 37.92% in 2025. The significant share of North America can be attributed to several factors, such as, the availability of various major manufacturers of automated cell counting products in the region, advanced medical infrastructure, developed economies, significant players, and established supply channels.

Automated Cell Counting Market Segmentation

Grand View Research has segmented the global automated cell counting market on the basis of product, application, end use, and region:

Automated Cell Counting Product Outlook (Revenue, USD Million, 2021 - 2033)

• Instruments      

  • Flow Cytometers

  • Image-based Cell Counters

  • Electrical Impendence Coulter Counters

• Consumables & Accessories 

Automated Cell Counting Application Outlook (Revenue, USD Million, 2021 - 2033)

• Blood Analysis

• Stem Cell Research

• Cell Line development

  • Biologics Production

  • Cell & Gene Therapy

• Others

Automated Cell Counting End Use Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & Biotechnology Companies

• Hospitals & Diagnostic laboratories

• Research & Academic Institutes

• Others

Automated Cell Counting Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Automated Cell Counting Market

• Thermo Fischer Scientific Inc.

• Countstar, Inc.

• Bio-Rad Laboratories, Inc.

• F. Hoffmann-La Roche Ltd

• Chemometec A/S

• Danaher

• Olympus Corporation

• MERCK KGaA

• Sysmex Corporation

• Agilent Technologies, Inc.

• Abbott